Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Whitney Ijem is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/11/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 05/31/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.12 | 169.94% | $109 → $111 | Maintains | Buy | Get Alert |
| 05/16/2024 | TNYA | Buy Now | Tenaya Therapeutics | $3.71 | 331.27% | $18 → $16 | Maintains | Buy | Get Alert |
| 05/15/2024 | PASG | Buy Now | Passage Bio | $1.07 | 1114.95% | $14 → $13 | Maintains | Buy | Get Alert |
| 05/10/2024 | ARCT | Buy Now | Arcturus Therapeutics | $32.42 | 165.27% | $87 → $86 | Maintains | Buy | Get Alert |
| 05/08/2024 | RYTM | Buy Now | Rhythm Pharmaceuticals | $41.12 | 92.12% | $80 → $79 | Maintains | Buy | Get Alert |
| 05/06/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.12 | 165.08% | $111 → $109 | Maintains | Buy | Get Alert |
| 04/26/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $83.91 | 6.07% | $91 → $89 | Maintains | Hold | Get Alert |
| 04/12/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $481.09 | -22.88% | $371 → $371 | Maintains | Sell | Get Alert |
| 03/21/2024 | TSHA | Buy Now | Taysha Gene Therapies | $3.91 | 79.03% | → $7 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | TNYA | Buy Now | Tenaya Therapeutics | $3.71 | 385.18% | $19 → $18 | Maintains | Buy | Get Alert |
| 03/19/2024 | RGLS | Buy Now | Regulus Therapeutics | $2.37 | 364.14% | $12 → $11 | Maintains | Buy | Get Alert |
| 03/11/2024 | ARCT | Buy Now | Arcturus Therapeutics | $32.42 | 168.35% | $81 → $87 | Maintains | Buy | Get Alert |
| 03/05/2024 | PASG | Buy Now | Passage Bio | $1.07 | 1208.41% | → $14 | Reiterates | Buy → Buy | Get Alert |
| 02/29/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $83.91 | 8.46% | → $91 | Reiterates | Hold → Hold | Get Alert |
| 02/23/2024 | NTLA | Buy Now | Intellia Therapeutics | $23.48 | 210.97% | $72 → $73 | Maintains | Buy | Get Alert |
| 02/21/2024 | RARE | Buy Now | Ultragenyx Pharmaceutical | $41.12 | 169.94% | $110 → $111 | Maintains | Buy | Get Alert |
| 01/24/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $481.09 | -21.22% | $332 → $379 | Downgrade | Hold → Sell | Get Alert |
| 12/13/2023 | ARCT | Buy Now | Arcturus Therapeutics | $32.42 | — | — | Initiates | → Buy | Get Alert |
| 09/21/2023 | RGLS | Buy Now | Regulus Therapeutics | $2.37 | 406.33% | $9 → $12 | Maintains | Buy | Get Alert |
| 09/20/2023 | TSHA | Buy Now | Taysha Gene Therapies | $3.91 | 53.45% | $7 → $6 | Maintains | Buy | Get Alert |
| 08/16/2023 | TSHA | Buy Now | Taysha Gene Therapies | $3.91 | 79.03% | $13 → $7 | Maintains | Buy | Get Alert |
| 08/11/2023 | RCKT | Buy Now | Rocket Pharmaceuticals | $22.44 | 109.45% | $49 → $47 | Maintains | Buy | Get Alert |
| 08/11/2023 | TNYA | Buy Now | Tenaya Therapeutics | $3.71 | 358.22% | $18 → $17 | Maintains | Buy | Get Alert |
| 08/07/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $481.09 | -34.52% | $312 → $315 | Maintains | Hold | Get Alert |
| 08/07/2023 | NTLA | Buy Now | Intellia Therapeutics | $23.48 | 176.89% | $66 → $65 | Maintains | Buy | Get Alert |
| 07/06/2023 | TSHA | Buy Now | Taysha Gene Therapies | $3.91 | 232.48% | → $13 | Reiterates | Buy → Buy | Get Alert |
| 07/05/2023 | SGTX | Buy Now | Sigilon Therapeutics | — | — | $6 → $30 | Maintains | Buy | Get Alert |
| 07/03/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $83.91 | 23.95% | $110 → $104 | Maintains | Hold | Get Alert |
| 06/16/2023 | VERV | Buy Now | Verve Therapeutics | $5.37 | 439.92% | → $29 | Reiterates | Buy → Buy | Get Alert |
| 04/13/2023 | NTLA | Buy Now | Intellia Therapeutics | $23.48 | 181.15% | → $66 | Initiates | → Buy | Get Alert |
